Systemic Anti-Cancer Therapy Regimen Library New Zealand Formulary

Sarcoma Regimens

Desmoid fibromatosis Regimens

Published Sort regimens by
Desmoid fibromatosis - metHOTREXATe and vinBLASTine Id: 265691000210100 Published date: Version: 1.0.0
265691000210100
1.0.0
17/09/2023
Desmoid fibromatosis - metHOTREXATe and vinORELBine Id: 264721000210107 Published date: Version: 1.0.0
264721000210107
1.0.0
02/07/2023

Giant Cell tumour of bone Regimens

Published Sort regimens by
Giant Cell tumour of bone - denosumab Id: 264671000210103 Published date: Version: 1.0.0
264671000210103
1.0.0
02/07/2023

Sarcoma Regimens

Published Sort regimens by
SAR Advanced/Metastatic - pembrolizumab Q6W [flat dosing] Id: 264701000210104 Published date: Version: 1.0.0
264701000210104
1.0.0
02/07/2023
SAR Advanced - pembrolizumab Q3W [flat dosing] Id: 264711000210102 Published date: Version: 1.0.0
264711000210102
1.0.0
02/07/2023
SAR Advanced - pembrolizumab Q3W [weight-based dosing] Id: 264681000210101 Published date: Version: 1.0.0
264681000210101
1.0.0
02/07/2023
SAR Angiosarcoma Advanced - PACLItaxel Id: 264691000210104 Published date: Version: 1.0.0
264691000210104
1.0.0
02/07/2023
SAR Kaposi Sarcoma - pegylated liposomal DOXOrubicin hydrochloride Id: 264651000210106 Published date: Version: 1.0.0
264651000210106
1.0.0
02/07/2023

Ewing Regimens

Published Sort regimens by
SAR Ewing sarcoma Relapsed - CYCLOPHOSPHamide and topotecan Id: 265561000210106 Published date: Version: 1.0.0
265561000210106
1.0.0
17/09/2023
SAR Ewing sarcoma Relapsed - irinotecan and temozolomide Id: 264731000210109 Published date: Version: 1.0.0
264731000210109
1.0.0
02/07/2023
SAR Ewing sarcoma - VAC, VC and IE [Q2W] Id: 312241000210108 Published date: Version: 1.0.0
Components ▾
VAC [vinCRISTine, daCTINomycin and CYCLOPHOSPHamide] Id: 312251000210106 Published date: Version: 0.0.9
IE [IFOSFamide and etoposide] Id: 265621000210103 Published date: Version: 0.0.11
VC [vinCRISTine and CYCLOPHOSPHamide] Id: 265631000210101 Published date: Version: 0.0.5
312241000210108
1.0.0
02/04/2024
SAR Ewing sarcoma - VAC, VC and IE [Q3W] Id: 312131000210107 Published date: Version: 1.0.0
Components ▾
VAC [vinCRISTine, daCTINomycin and CYCLOPHOSPHamide] Id: 312141000210104 Published date: Version: 0.0.17
IE [IFOSFamide and etoposide] Id: 312111000210100 Published date: Version: 0.0.9
VC [vinCRISTine and CYCLOPHOSPHamide] Id: 312121000210105 Published date: Version: 0.0.4
312131000210107
1.0.0
02/04/2024
SAR Ewing sarcoma - VDC, VC and IE [Q2W] Id: 497041000210106 Published date: Version: 1.0.0
Components ▾
VDC [vinCRISTine, DOXOrubicin and CYCLOPHOSHamide] Id: 497051000210109 Published date: Version: 0.0.10
IE [IFOSFamide and etoposide] Id: 265621000210103 Published date: Version: 0.0.11
VC [vinCRISTine and CYCLOPHOSPHamide] Id: 265631000210101 Published date: Version: 0.0.5
497041000210106
1.0.0
13/03/2025
SAR Ewing sarcoma - VDC, VC and IE [Q3W] Id: 312091000210109 Published date: Version: 1.0.0
Components ▾
VDC [vinCRISTine, DOXOrubicin and CYCLOPHOSPHamide] Id: 312101000210102 Published date: Version: 0.0.10
IE [IFOSFamide and etoposide] Id: 312111000210100 Published date: Version: 0.0.9
VC [vinCRISTine and CYCLOPHOSPHamide] Id: 312121000210105 Published date: Version: 0.0.4
312091000210109
1.0.0
02/04/2024
SAR Ewing sarcoma - VDC with dexrazoxane, VC and IE [Q2W] Id: 265601000210106 Published date: Version: 1.0.0
Components ▾
VDC [vinCRISTine, DOXOrubicin and CYCLOPHOSPHamide] with dexrazoxane Id: 265611000210108 Published date: Version: 0.0.11
IE [IFOSFamide and etoposide] Id: 265621000210103 Published date: Version: 0.0.11
VC [vinCRISTine and CYCLOPHOSPHamide] Id: 265631000210101 Published date: Version: 0.0.5
265601000210106
1.0.0
17/09/2023

Osteosarcoma Regimens

Published Sort regimens by
SAR Osteosarcoma Advanced - DOXOrubicin [1-day dosing] and cISplatin Id: 265571000210100 Published date: Version: 2.0.0
265571000210100
2.0.0
08/05/2026
SAR Osteosarcoma Advanced - DOXOrubicin [3-day split dosing] and cISplatin Id: 265541000210105 Published date: Version: 2.0.0
265541000210105
2.0.0
08/05/2026
SAR Osteosarcoma - MAP [metHOTREXATe, DOXOrubicin and cISplatin] Id: 312061000210104 Published date: Version: 1.0.0
Components ▾
Part 1: MAP [metHOTREXATe, DOXOrubicin and cISplatin] Id: 312071000210105 Published date: Version: 0.0.22
Part 2: MA [metHOTREXATe and DOXOrubicin] Id: 312081000210107 Published date: Version: 0.0.14
312061000210104
1.0.0
02/04/2024

Rhabdomyosarcoma Regimens

Published Sort regimens by
SAR Rhabdomyosarcoma Relapsed - VIT [vinCRISTine, irinotecan and temozolomide] Id: 265551000210108 Published date: Version: 2.0.0
265551000210108
2.0.0
24/08/2026
SAR Rhabdomyosarcoma - VAC, VC, vinCRISTine and VI [ARST0531] [intermediate risk] Id: 497061000210107 Published date: Version: 1.0.0
Components ▾
ARST0531 [intermediate risk] - VAC + VV [vinCRISTine days 1, 8 and 15, daCTINomycin and CYCLOPHOSPHamide] Id: 497071000210101 Published date: Version: 0.0.7
ARST0531 [intermediate risk] - V, Irin + VV [vinCRISTine days 1, 8 and 15 and irinotecan] Id: 497081000210104 Published date: Version: 0.0.6
ARST0531 [intermediate risk] - VC + VV [vinCRISTine days 1, 8 and 15 and CYCLOPHOSPHamde] Id: 497091000210102 Published date: Version: 0.0.7
ARST0531 [intermediate risk] - VAC [vinCRISTine, daCTINomycin and CYCLOPHOSPHamde] Id: 497101000210109 Published date: Version: 0.0.5
ARST0531 [intermediate risk] - V, Irin + V [vinCRISTine days 1 and 8 and irinotecan] Id: 497111000210106 Published date: Version: 0.0.6
497061000210107
1.0.0
13/03/2025
SAR Rhabdomyosarcoma - vinCRISTine, daCTINomycin and CYCLOPHOSPHamide [ARST0331] [low risk] Id: 497121000210101 Published date: Version: 1.0.0
Components ▾
ARST0331 [low risk] - VAC + VV [vinCRISTine days 1, 8 and 15, daCTINomycin and CYCLOPHOSPHamide] Id: 497131000210104 Published date: Version: 0.0.6
ARST0331 [low risk] - AC [daCTINomycin and CYCLOPHOSPHamide] Id: 497141000210107 Published date: Version: 0.0.5
ARST0331 [low risk] - VA + VV [vinCRISTine days 1, 8 and 15, daCTINomycin] WITHOUT radiotherapy Id: 497151000210105 Published date: Version: 0.0.6
ARST0331 [low risk] - VA + VV [vinCRISTine days 1, 8 and 15, daCTINomycin] WITH radiotherapy Id: 497161000210108 Published date: Version: 0.0.5
ARST0331 [low risk] - A [daCTINomycin] Id: 497171000210102 Published date: Version: 0.0.5
497121000210101
1.0.0
13/03/2025
SAR Rhabdomyosarcoma - vinCRISTine, irinotecan, IFOSFamide, etoposide, DOXOrubicin, CYCLOPHOSPHamide and daCTINomycin [ARST0431] [high risk] Id: 312151000210101 Published date: Version: 1.0.0
Components ▾
ARST0431 [high risk] - V, Irin + VV [vinCRISTine days 1, 8 and 15 and irinotecan] Id: 312161000210103 Published date: Version: 0.0.12
ARST0431 [high risk] - V, Irin + V [vinCRISTine days 1 and 8 and irinotecan] Id: 312171000210109 Published date: Version: 0.0.11
ARST0431 [high risk] - VDC + V [vinCRISTine days 1 and 8, DOXOrubicin and CYCLOPHOSPHamide] [Q2W] Id: 312181000210106 Published date: Version: 0.0.12
ARST0431 [high risk] - IE [IFOSFamide and etoposide] [Q2W] Id: 312191000210108 Published date: Version: 0.0.2
ARST0431 [high risk] - IE [IFOSFamide and etoposide] [Q3W] Id: 312201000210105 Published date: Version: 0.0.2
ARST0431 [high risk] - VDC + V [vinCRISTine days 1 and 8, DOXOrubicin and CYCLOPHOSPHamide] [Q3W] Id: 312211000210107 Published date: Version: 0.0.3
ARST0431 [high risk] - VAC [vinCRISTine, daCTINomycin and CYCLOPHOSPHamide] Id: 312221000210102 Published date: Version: 0.0.4
ARST0431 [high risk] - VAC + VV [vinCRISTine days 1, 8 and 15, daCTINomycin and CYCLOPHOSPHamide] Id: 312231000210100 Published date: Version: 0.0.6
312151000210101
1.0.0
02/04/2024

STS Regimens

Published Sort regimens by
SAR STS Advanced - DOXOrubicin Id: 264661000210109 Published date: Version: 2.0.0
264661000210109
2.0.0
08/05/2026
SAR STS Advanced - DOXOrubicin and IFOSFamide 20/2000 Id: 265581000210103 Published date: Version: 2.0.0
265581000210103
2.0.0
24/08/2026
SAR STS Advanced - DOXOrubicin and IFOSFamide 25/3000 Id: 265591000210101 Published date: Version: 2.0.0
265591000210101
2.0.0
24/08/2026
SAR STS Advanced - IFOSFamide [3-day] Id: 265641000210109 Published date: Version: 2.0.0
265641000210109
2.0.0
24/08/2026
SAR STS Advanced - pAZOPanib Id: 265651000210107 Published date: Version: 1.0.0
265651000210107
1.0.0
17/09/2023
SAR STS Advanced - trabectedin Id: 265661000210105 Published date: Version: 1.0.0
265661000210105
1.0.0
17/09/2023
SAR STS - IFOSFamide and DOXOrubicin [ARST0332] [intermediate and high risk] Id: 497181000210100 Published date: Version: 1.0.0
Components ▾
ARST0332 [intermediate and high risk] - ID [IFOSFamide and DOXOrubicin] Id: 497191000210103 Published date: Version: 0.0.13
ARST0332 [intermediate and high risk] - I [IFOSFamide] Id: 497201000210101 Published date: Version: 0.0.10
ARST0332 [intermediate and high risk] - D [DOXOrubicin] Id: 497211000210104 Published date: Version: 0.0.7
497181000210100
1.0.0
13/03/2025
SAR STS Metastatic - DOCEtaxel and gemcitabine 675 [GeDDis] Id: 265671000210104 Published date: Version: 1.0.0
265671000210104
1.0.0
17/09/2023
SAR STS Metastatic - DOCEtaxel and gemcitabine 900 Id: 265681000210102 Published date: Version: 1.0.0
265681000210102
1.0.0
17/09/2023